Analysts expect Caribou Biosciences, Inc. to report revenue of 2.02 M for Q3 26, against a range of 1.96 M to 2.08 M. The most recent reported quarter, Q2 26, came in at 1.50 M, a 36.0% miss against the 2.35 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.02 M | 2.08 M | 2.35 M | 2.67 M | 2.20 M | 3.94 M | 2.40 M | 1.50 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 3.50 M | 2.15 M | 1.80 M | 1.90 M | 2.50 M | 2.23 M | 2.23 M | 2.54 M | 2.08 M | 21.63 M | 2.60 M | 1.12 M | 802,801.55 | 8.22 M | 2.84 M | 1.36 M | ||||||||||
| Low Estimate | 2.91 M | 1.90 M | 1.58 M | 1.71 M | 2.18 M | 1.90 M | 1.98 M | 2.15 M | 1.96 M | 20.31 M | 2.30 M | 966,072.03 | 683,914.79 | 7.13 M | 2.52 M | 1.19 M | ||||||||||
| Consensus Estimate | 3.20 M | 2.02 M | 1.69 M | 1.81 M | 2.34 M | 2.06 M | 2.11 M | 2.35 M | 2.02 M | 20.97 M | 2.45 M | 1.04 M | 743,358.17 | 7.68 M | 2.68 M | 1.27 M |
Analysts expect Caribou Biosciences, Inc. to report earnings per share of -0.30 for Q3 26, against a range of -0.33 to -0.27. The most recent reported quarter, Q2 26, came in at -0.24, a 20.0% beat against the -0.30 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.38 | -0.39 | -0.43 | -0.35 | -0.30 | -0.28 | -0.26 | -0.24 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.39 | -0.43 | -0.38 | -0.34 | -0.33 | -0.27 | -0.26 | -0.29 | -0.27 | -0.16 | -0.31 | -0.30 | -0.37 | -0.29 | -0.35 | -0.35 | ||||||||||
| Low Estimate | -0.47 | -0.47 | -0.44 | -0.42 | -0.39 | -0.31 | -0.32 | -0.31 | -0.33 | -0.20 | -0.33 | -0.34 | -0.41 | -0.31 | -0.41 | -0.39 | ||||||||||
| Consensus Estimate | -0.43 | -0.45 | -0.41 | -0.38 | -0.36 | -0.29 | -0.29 | -0.30 | -0.30 | -0.18 | -0.32 | -0.32 | -0.39 | -0.30 | -0.38 | -0.37 |
Pull Wall Street consensus for Caribou Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CRBU&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CRBU", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CRBU&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();